rheumatology
Medicines

Further reassurance over cancer risk with biologics

Treating rheumatoid arthritis with biologics does not lead to an increased risk of cancer or cancer recurrence, new data shows. Presenting the findings of one of the studies here at this year’s EULAR congress here in Madrid Professor Johan Askling from the Karolinska Institute in Stockholm, Sweden, said the inhibition of TNF could ‘theoretically’ increase ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic